CMS has completed two negotiation cycles so far: the first set of 10 drugs took effect in 2026, and a second set of 15 drugs, including Ozempic and Wegovy, takes effect in 2027.
Dulaglutide is another weekly GLP-1 receptor agonist used in type 2 diabetes
The fixture itself contains a traditional single tube element with an incredible clear, bright, white output, derived from 216 white LEDs, and then combines that with a surrounding, format-filling full face of RGB LED power, utilizing 1,320 high quality LEDs
The SUSTAIN-6 study demonstrated a 26% reduction in major adverse cardiovascular events (MACE), which includes cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in high-risk patients with type 2 diabetes
Our landmark trial, SELECT, showed that Wegovy is associated with a significant 20% risk reduction of cardiovascular events, backed up with even greater risk reductions in the real-world studies SCORE and STEER
So while the Wolverine Stack may have supported this individuals recovery, we cant say it was the clear cause